📰 Diffusion Pharmaceuticals News
Page 7 - Diffusion Pharmaceuticals News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Diffusion Pharmaceuticals. Real-time updates on events, politics, business and more.
April 6, 2023
StockNews.com began coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a research report sent to investors on Monday. The firm issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Performance DFFN opened at $3.92 on Monday. The business’s 50-day simple moving average is $5.81 and its 200 day simple moving average […]
April 3, 2023
Equities researchers at StockNews.com started coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a report released on Monday. The firm set a “hold” rating on the stock. Diffusion Pharmaceuticals Trading Down 3.5 % Shares of Diffusion Pharmaceuticals stock opened at $4.15 on Monday. The company has a market cap of $8.47 million, […]
April 3, 2023
Research Analysts’ new coverage for Monday, April 3rd: StockNews.com initiated coverage on shares of Almaden Minerals (NYSEAMERICAN:AAU) (TSE:AMM). They issued a sell rating on the stock. StockNews.com initiated coverage on shares of Atlas Air Worldwide (NASDAQ:AAWW). StockNews.com issued a hold rating on the stock. StockNews.com initiated coverage on shares of Advanced Emissions Solutions (NASDAQ:ADES). They […]
March 30, 2023
The rise in the incidence of ARDS stimulates the research and development of the drug, as it is likely to provide an appropriate environment for newer products to be profitable. Companies across
March 30, 2023
The rise in the incidence of ARDS stimulates the research and development of the drug, as it is likely to provide an appropriate environment for newer products...
March 30, 2023
/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...
March 30, 2023
Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN – Get Rating) was the target of a large drop in short interest in March. As of March 15th, there was short interest totalling 9,500 shares, a drop of 61.1% from the February 28th total of 24,400 shares. Approximately 0.5% of the company’s stock are short sold. Based on an average […]
March 29, 2023
StockNews.com began coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a research report released on Sunday. The brokerage issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Down 5.8 % NASDAQ DFFN opened at $4.86 on Friday. Diffusion Pharmaceuticals has a twelve month low of $4.64 and a twelve month high […]
March 26, 2023
Research Analysts’ new coverage for Sunday, March 26th: StockNews.com assumed coverage on shares of Almaden Minerals (NYSEAMERICAN:AAU) (TSE:AMM). The firm issued a sell rating on the stock. StockNews.com assumed coverage on shares of Atlas Air Worldwide (NASDAQ:AAWW). The firm issued a hold rating on the stock. StockNews.com began coverage on shares of Advanced Emissions Solutions […]
March 23, 2023
Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) is set to post its quarterly earnings results on Friday, March 24th. Diffusion Pharmaceuticals Trading Down 3.3 % NASDAQ:DFFN traded down $0.19 during midday trading on Thursday, reaching $5.65. The company had a trading volume of 4,032 shares, compared to its average volume of 7,947. The firm has a […]